Inotersen FDA approval date

The FDA approved Inotersen (IONIS-TTR Rx) on 5 Oct 2018.

FDA approval date
5 Oct 2018

Drug identity checked against registry records

Also recorded as IONIS-TTR Rx; ISIS 420915; TEGSEDI

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-10-05DayInotersenFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA211172", "applicant_as_listed_by_fda": "AKCEA THERAPS", "brand_names": ["TEGSEDI"], "active_ingredients": ["INOTERSEN SODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20181005", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026